These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8192683)

  • 1. Opiate receptors--the historical breakthrough in drug research.
    Terenius L
    Biochem Soc Symp; 1993; 59():13-25. PubMed ID: 8192683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Opioid receptors in the era of molecular biology: they account for more than 6,000 years of empirical pharmacology].
    Huidobro-Toro JP
    Rev Med Chil; 1995 May; 123(5):628-36. PubMed ID: 8525211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 75 years of opioid research: the exciting but vain quest for the Holy Grail.
    Corbett AD; Henderson G; McKnight AT; Paterson SJ
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S153-62. PubMed ID: 16402099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An opiate cocktail that reduces morphine tolerance and dependence.
    He L; Whistler JL
    Curr Biol; 2005 Jun; 15(11):1028-33. PubMed ID: 15936273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids: cellular mechanisms of tolerance and physical dependence.
    Bailey CP; Connor M
    Curr Opin Pharmacol; 2005 Feb; 5(1):60-8. PubMed ID: 15661627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
    Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
    Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction.
    Nestler EJ
    Trends Pharmacol Sci; 2004 Apr; 25(4):210-8. PubMed ID: 15063085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.
    Kreek MJ; Schlussman SD; Bart G; Laforge KS; Butelman ER
    Neuropharmacology; 2004; 47 Suppl 1():324-44. PubMed ID: 15464148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ambiguities of opioid tolerance mechanisms: barriers to pain therapeutics or new pain therapeutic possibilities.
    Gintzler AR; Chakrabarti S
    J Pharmacol Exp Ther; 2008 Jun; 325(3):709-13. PubMed ID: 18354057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biphasic opioid function modulator: agmatine.
    Su RB; Li J; Qin BY
    Acta Pharmacol Sin; 2003 Jul; 24(7):631-6. PubMed ID: 12852826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian opiate alkaloid synthesis: lessons derived from plant biochemistry.
    Meijerink WJ; Molina PE; Abumrad NN
    Shock; 1999 Sep; 12(3):165-73. PubMed ID: 10485593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical review: Opioid receptors.
    Snyder SH; Pasternak GW
    Trends Pharmacol Sci; 2003 Apr; 24(4):198-205. PubMed ID: 12707007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence.
    Law PY; Loh HH; Wei LN
    Neuropharmacology; 2004; 47 Suppl 1():300-11. PubMed ID: 15464146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.